FDA Approved: TOUJEO — Supplemental Application (Sanofi-Aventis U.S. LLC)

View source ↗

Summary

FDA approves a supplemental application for Toujeo (insulin glargine) submitted by Sanofi-Aventis U.S. LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• TOUJEO (insulin glargine)

Snippet

SUPPL AP for TOUJEO (INSULIN GLARGINE)